{
    "clinical_study": {
        "@rank": "112571", 
        "brief_summary": {
            "textblock": "How are the health related quality of life among patients with chronic pain effected by\n      interventional pain managment?\n\n      Hypothesis:\n\n      Health related quality of life can be improved by interventional pain management both among\n      patients with localizable pain focuses and among patients among whom no pain focuses can be\n      found.\n\n      Method:\n\n      Health related quality of life using EQ-5D and EQ-VAS is registered at first visit, at the\n      time of treatment for pain focuses an during the following 12 months."
        }, 
        "brief_title": "Effects on Health Related Quality of Life Among Patients With Chronic Pain by Interventional Pain Management", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Pain", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        All patients\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "15 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients referred to a specialized interventional pain management clinic in northen sweden"
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01836666", 
            "org_study_id": "SE-Dnr-2012-446-31M-1"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 17, 2013", 
        "location": {
            "contact": {
                "email": "johan@smartkliniken.eu", 
                "last_name": "Johan Hambraeus, MD", 
                "phone": "+46706293798"
            }, 
            "contact_backup": {
                "last_name": "Eva Umaerus, RN", 
                "phone": "+4690186018"
            }, 
            "facility": {
                "address": {
                    "city": "Ume\u00e5", 
                    "country": "Sweden", 
                    "zip": "90325"
                }, 
                "name": "Sm\u00e4rtkliniken i Ume\u00e5"
            }, 
            "investigator": [
                {
                    "last_name": "Johan Hambraeus, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Fredrik Campbell, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Kjerstin Segerstedt Hambraeus, RN", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_groups": "1", 
        "official_title": "Effects on Health Related Quality of Life Among Patients With Chronic Pain by Interventional Pain Management", 
        "overall_contact": {
            "email": "johan@smartkliniken.eu", 
            "last_name": "Johan Hambraeus, MD", 
            "phone": "+46706293798"
        }, 
        "overall_official": {
            "last_name": "Johan Hambraeus, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "EQ-VAS is measured at first visit, at time for treatment and 3, 6 and 12 months after treatment. EQ-VAS gives a value of quality of life, and mainly used to verify the results achieved from EQ-5D since it is not possible to calculate QALY from EQ-VAS", 
                "measure": "EQ-VAS", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "EQ-5D is assessed at first visit, at time for treatment and 3, 6 and 12 months after treatment. Quality of life is calculated from EQ-5D using the TTO-valuated UK value sets. This value can also be used for calculation of QALY, Quality adjusted life years.", 
                "measure": "EQ-5D", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01836666"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Eques Indolor AB", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Eques Indolor AB", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Observational Model: Ecologic or Community, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Year", 
        "verification_date": "April 2013"
    }
}